Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | NAAA | Q02083 | 2/20 | 0.58 |
| ▸ | FAAH | O00519 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.45 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9576503 | 1.00 | LMNA (0.68) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL1070537 | 1.00 | LMNA (0.68) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL6724069 | 1.00 | LMNA (0.68) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL9576491 | 0.98 | LMNA (0.70) | LMNANAAAFAAHL3MBTL1MEN1 | |
| Bicarbonate SCHEMBL5682661 | 0.97 | LMNA (0.64) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL31632703 | 0.95 | LMNA (0.61) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL4331647 | 0.95 | LMNA (0.61) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL9576439 | 0.95 | LMNA (0.61) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL6863387 | 0.95 | LMNA (0.61) | LMNANAAAFAAHL3MBTL1MEN1 | |
| SCHEMBL8378836 | 0.95 | LMNA (0.61) | LMNANAAAFAAHL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116370378-A | Licorice root extract skin care product composition and preparation method thereof | 广东诗漾医疗科技有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | Ananda Scientific, Inc. (US) | 2025-06-19 | — | — | US | disclosed |
| CN-118139961-A | Water-soluble films and methods of use | 诺赫博股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-116370378-B | Licorice root extract skin care product composition and preparation method thereof | 广东诗漾医疗科技有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116370378-A | Licorice root extract skin care product composition and preparation method thereof | 广东诗漾医疗科技有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2012167243-A1 | COMPOSITIONS AND METHODS OF TREATMENT FOR OBESITY | B & P COMPANY, INC. (US) | 2012-12-06 | — | — | WO | disclosed |
| WO-2007077333-A2 | USE OF A NEUROPEPTIDE Y ANTAGONIST FOR DAMAGED OR SENSITIVE LIPS | L'OREAL (FR) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007077334-A2 | USE OF A NEUROPEPTIDE Y AGONIST FOR PLUMPING AND/OR NATURALLY COLOURING LIPS | L'OREAL (FR) | 2007-07-12 | — | — | WO | disclosed |
| EP-0257086-B1 | SKINPENETRATION ENHANCING COMPOSITIONS | WHITBY RESEARCH, Inc. (US) | 1993-01-20 | — | — | EP | disclosed |
| EP-0268218-B1 | PENETRATION ENHANCERS FOR TRANSDERMAL DELIVERY OF SYSTEMIC AGENTS | WHITBY RESEARCH, Inc. (US) | 1992-05-06 | — | — | EP | disclosed |
| US-5043441-A | Enhance penetration of active materials through skin | WHITBY RESEARCH, INC. (US) | 1991-08-27 | — | — | US | disclosed |
| US-5034386-A | Fungicides | WHITBY RESEARCH, INC. (US) | 1991-07-23 | — | — | US | disclosed |
| US-4886783-A | Penetration enhancers for transdermal delivery of systemic agents | NELSON RESEARCH & DEVELOPMENT CO. (US) | 1989-12-12 | — | — | US | disclosed |
| US-4886545-A | IMPROVE DELIVERY OF PLANT NUTRIENTS | NELSON RESEARCH & DEVELOPMENT COMPANY (US) | 1989-12-12 | — | — | US | disclosed |
| EP-0268218-A2 | Penetration enhancers for transdermal delivery of systemic agents | WHITBY RESEARCH, Inc. (US) | 1988-05-25 | — | — | EP | disclosed |
| US-4716060-A | ACYCLIC OR HETEROCYCLIC TERTIARY AMIDE | RAJADHYAKSHA VITHAL J (US) | 1987-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195409-A1 | METHODS FOR IMPROVING CUTANEOUS PERMEATION OF CANNABINOIDS AND FATTY ACID AMIDES | CNR2, CNR1, FAAH | LMNA 3441/4885NAAA 77/4885FAAH 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.